Trademark Docketing · France

Trademark Docketing in Lyon.

Trademark docketing Lyon pharma brands trust: track INPI 10-year renewals, EUTM and Madrid clocks and INPI opposition deadlines. Book a docketing review today.

trademark docketing Lyon deadline calendar tracking INPI 10-year national renewals, EUTM and WIPO Madrid clocks and INPI opposition and non-use revocation deadlines by PerspireIP

Trademark docketing Lyon life-science companies rely on has to carry something a single renewal calendar never shows: a French brand that is attacked, opposed or challenged now faces most of those fights inside the INPI rather than in a courtroom, so the response deadlines land on the very same docket as the renewals. Lyon is France’s life-science and chemicals powerhouse — Sanofi Pasteur’s vaccines campus at Marcy-l’Étoile, bio­Mérieux’s diagnostics headquarters, Boiron at Messimy, Arkema’s research base in the Vallée de la Chimie, and the Lyonbiôpole health cluster. These are multi-class pharma and chemical portfolios filed across France, the EU and the Madrid system at once, where one missed date can unravel a brand worth more than the molecule. PerspireIP builds the docket that keeps every clock visible.

Why trademark docketing Lyon pharma portfolios run on three separate clocks

The trademark docketing Lyon life-science teams require is harder than almost any other French calendar, because a Lyon pharma brand is rarely a single registration on a single register. A vaccine, a diagnostic assay or a specialty-chemical name is typically protected at the same time as a French national mark at the INPI, an EU trade mark (EUTM) at the EUIPO in Alicante, and a Madrid international registration administered by WIPO in Geneva. Each of those sits on its own ten-year renewal clock, with its own window, its own fee and its own last safe day — and none of them is triggered by the others.

Lyon is exactly the economy where that multiplies fast. These owners protect one brand across several Nice classes at once — pharmaceuticals in class 5, chemicals in class 1, medical devices in class 10 — so a single product name can carry a dozen live deadlines across three offices, and the Lyonbiôpole cluster seeds new biotech spin-outs that repeat the pattern every year.

  • Three offices, three clocks — the INPI for French marks, the EUIPO for EU trade marks, and WIPO for Madrid international registrations
  • Multi-class by nature — pharma and chemical brands span classes 1, 5, 10 and more, each class adding official fees at renewal
  • Contentious dates too — since 2020 oppositions, non-use revocation and many nullity actions are decided at the INPI, so their deadlines sit on the docket
  • No reliable reminder — the offices do not dependably mail renewal or deadline notices, so the docket is the only safeguard

French national renewals at the INPI: ten years, a one-year window and a grace surcharge

The French layer runs on dates, not goodwill. A French registration lasts ten years from its filing date and is renewable indefinitely in ten-year periods. Since the ordinance of 13 November 2019 transposed the EU Trade Mark Directive under the loi PACTE, renewal may be requested across the whole year before the expiry date, filed electronically on the INPI’s online portal rather than on paper. The mark now falls due on the exact anniversary of its filing date, so the precise day — not merely the month — is what the docket must hold.

Miss the deadline and the mark is not lost at once. A six-month grace period (délai de grâce) runs from the day after expiry, during which renewal is still possible on payment of a surcharge. Only when that window closes unpaid is the registration definitively struck from the register. Because the offices do not reliably send a renewal notice, a Lyon owner that has moved premises or changed counsel since filing cannot rely on a prompt arriving — the docket is the safeguard.

Fees are charged per class and the INPI revises its schedule periodically, so we confirm the live figures before every payment. As a current guide the renewal fee is €290 for the first class and €40 for each additional class, with a late-renewal surcharge of around €145 added during the grace period. For a Lyon pharma mark registered across four or five Nice classes, those per-class amounts stack quickly, so the docket flags the one-year window early enough to renew deliberately rather than under surcharge.

  • Term — ten years from the filing date, renewable in ten-year periods indefinitely
  • Window — the whole year before expiry, filed electronically on the INPI portal
  • Grace period — six months after expiry on payment of the roughly €145 surcharge
  • Per-class fees — about €290 for the first class and €40 per additional class, confirmed live before paying

The trademark docketing Lyon needs for multi-class pharma and the EUTM

Why keep the French national renewal and the EU trade mark on two separate lines of the same docket? Because they are two different rights, due on two different days, paid to two different offices — and a Lyon life-science owner almost always holds both. The French mark covers France; the EUTM covers all twenty-seven member states from one registration. Renewing one does nothing for the other, and the two deadlines rarely coincide even when the brand feels like a single asset.

An EUTM also lasts ten years from its filing date and renews in ten-year periods, with its own advance window and grace period, but the EUIPO fee structure and the exact date are wholly independent of anything the INPI does. The EUIPO charges per class as well, so a diagnostics or vaccine brand claimed across classes 1, 5 and 10 pays additional-class fees twice over: once in France and once at the EU level. Treating the pair as one “renewal” entry is how a company protects its brand in Europe while quietly letting the French national right lapse — or the reverse.

  • Two rights, two offices — the French national mark at the INPI and the EUTM at the EUIPO, each renewed and paid separately
  • Two fee schedules — additional-class fees are charged independently at national and EU level, so multi-class pharma portfolios pay twice
  • Dates rarely align — a national filing anniversary and an EUTM filing anniversary are set years apart in most portfolios
  • Never merge the line — a single “renewal” entry for both is the classic route to a lapsed right

INPI oppositions now sit on the same docket as renewals

The reform that most changed a French docket is the one most calendars still ignore: contentious deadlines now run through the INPI, not only the courts. Under the loi PACTE, the opposition procedure was overhauled for French marks — and international marks designating France — filed on or after 11 December 2019. A third party may oppose registration within two months of the publication of an application, a deadline with no possible extension, and may now base a single opposition on several earlier rights at once, including earlier marks, company names, trade names and even domain names.

For a Lyon brand owner this cuts both ways, and both ways produce diary dates. When you oppose a conflicting mark, the official fee is around €400 for one earlier right plus roughly €150 per additional right relied on. When your own application is opposed, you have two months to file observations in reply, and the written adversarial phase then runs in exchanges until a party stops responding; the INPI must issue its decision within three months of the close of that phase, so the whole proceeding typically takes six months to a year. Each of those reply windows is as fatal to miss as a renewal.

  • Two-month filing window — opposition must be lodged within two months of publication, with no extension
  • Multiple grounds — one opposition can now rest on several earlier rights at about €400 plus €150 per extra right
  • Two-month reply — a Lyon applicant that is opposed must file observations within two months, then exchange through the adversarial phase
  • Three-month decision — the INPI rules within three months of the adversarial phase closing, so the docket tracks every intermediate date

Administrative non-use revocation and nullity before the INPI

Alongside oppositions, the loi PACTE moved revocation for non-use (déchéance) and many nullity (nullité) actions into the INPI from 1 April 2020. A registered French mark that has not been put to genuine use for an uninterrupted period of five years becomes vulnerable to revocation, and the challenge can now be filed online by almost anyone, with no prior right required for a non-use action. The owner carries the burden of proving genuine use, class by class, for the relevant period.

The administrative route was built to be fast and cheap, which is precisely why it is dangerous for a dormant mark. The official fee sits around €600, the procedure is fully electronic, and it is capped so it cannot drag on — broadly a nine-month ceiling once the adversarial phase is under way. For Lyon’s pharma and biotech owners the exposure is acute: defensive marks filed across many Nice classes to fence a molecule often go unused in several of those classes, and a competitor clearing the way for its own brand can pick them off cheaply.

That makes the docket an evidence discipline, not only a date calendar. For every registration we flag the five-year non-use exposure and keep contemporaneous proof — dated invoices, packaging, regulatory filings, trade-show and advertising material — so a revocation notice never lands on an owner reconstructing use from memory under a tight reply deadline.

  • Five-year rule — an uninterrupted five-year gap in genuine use opens a mark to revocation
  • Administrative since 1 April 2020 — the INPI decides non-use revocation and many nullity grounds, with an official fee near €600
  • Capped and electronic — a roughly nine-month ceiling and an online filing make dormant marks quick and cheap to attack
  • Evidence discipline — the five-year date is flagged and dated proof of use kept current for every class

The separate EUTM and WIPO Madrid clocks a Lyon portfolio carries

Lyon’s life-science brands rarely stop at France and the EU. Vaccine, diagnostic and specialty-chemical names sell into dozens of markets, so owners routinely reach them through the Madrid Protocol, filing one international application that matures into an international registration (IR) administered by WIPO in Geneva. That adds a further, entirely independent renewal clock to the docket.

A Madrid IR is renewed centrally through WIPO on the IR’s own ten-year anniversary — a single payment that covers every designated country, set by the international registration itself and unconnected to any French or EU date. Crucially, the IR also carries a five-year dependency period: for its first five years it hangs on the base mark, so if that base French or EU mark is cancelled or revoked, the whole IR can fall in a “central attack” across all its designations. A Lyon brand can therefore sit on a French deadline, an EU deadline and an international deadline that never coincide, with a dependency risk layered over the first five years.

  • WIPO renewal — the IR renews centrally in Geneva on its own ten-year cycle, separate from every French and EU date
  • One payment, many countries — the Madrid renewal covers all designated territories in a single WIPO transaction
  • Five-year dependency — the IR hangs on the base mark for five years and is open to central attack if that base right falls
  • One docket, three systems — national, EU and international clocks must sit side by side and never merge into one entry

How PerspireIP runs a Lyon trademark docket

The trademark docketing Lyon founders and in-house counsel actually need starts with a reconciliation, not a reminder. We take the register extract and lay every brand out across its three possible clocks — the French national mark at the INPI, the EUTM at the EUIPO, and any Madrid IR at WIPO — so the national, EU and international rights for one product name are never again mistaken for a single renewal. Multi-class pharma and chemical marks are broken down class by class, because each class drives both the renewal fee and the non-use exposure.

From there we build a living docket that surfaces every deadline well before it bites: the ten-year French renewal and its one-year window, the EUTM and Madrid anniversaries, the five-year non-use date for each class, and — the piece most calendars omit — the INPI contentious deadlines, so an opposition reply or a revocation defence is diarised with the same rigour as a renewal. The per-class fee is confirmed against the INPI’s current schedule before every payment rather than quoted from memory.

  • Three-clock reconciliation — every brand mapped across INPI, EUIPO and WIPO rights, class by class
  • Renewal calendar — the full French one-year window and six-month grace docketed, with the live INPI per-class fee confirmed
  • Contentious dates — opposition two-month windows, reply deadlines and revocation timelines surfaced early
  • Non-use defence — the five-year date flagged and dated proof of use kept current for every class
  • Madrid tracking — WIPO renewals and the five-year dependency period docketed alongside the national clocks
  • One point of control — INPI, EUIPO and WIPO deadlines managed centrally, with reminders that never depend on an office mailing a notice

We work alongside your French trademark attorney and in-house team as a specialist docketing partner, keep every matter confidential, and scale from a handful of marks to a full international programme. Send us the register extract and we will return a clean, reconciled docket with every French, EU and international deadline — renewals and INPI contentious dates alike — mapped and dated.

IP Landscape & Resources in Lyon

Key intellectual-property authorities and venues relevant to Lyon:

  • INPI (Institut national de la propriete industrielle) — the French office that administers the national trademark register, applies the post-2019 renewal reform and per-class fees, and since 2020 decides oppositions, non-use revocation and many nullity actions administratively
  • INPI – opposing the registration of a trademark — the INPI's official e-procedure and timeline for the post-PACTE opposition, including the two-month filing window and the reply deadlines a docket must track
  • EUIPO (European Union Intellectual Property Office) — administers the EU trade mark, which runs on its own ten-year renewal clock from filing with its own per-class fees, separate from any French national deadline
  • WIPO – Madrid System — administers the Madrid Protocol; international registrations are renewed centrally through WIPO in Geneva on the IR's own ten-year anniversary and carry a five-year dependency on the base mark

Request Trademark Docketing in Lyon

Request Trademark Docketing in Lyon

From the INPI ten-year renewal window and its grace surcharge to the EUTM and WIPO Madrid clocks and the INPI opposition and revocation deadlines, PerspireIP builds a reconciled docket that keeps every Lyon deadline visible. Send us your register extract and we will map every clock and confirm the next steps within one business day.

Explore related PerspireIP services: Trademark Docketing · Trademark Filing · Trademark Search · trademark docketing in Paris.

Frequently Asked Questions

How are French trademark renewals handled at the INPI for a Lyon brand?

A French registration lasts ten years from its filing date and renews in ten-year periods. Since the loi PACTE reform renewal may be requested throughout the whole year before expiry, filed electronically on the INPI portal, and falls due on the exact filing anniversary. If the date is missed, a six-month grace period allows late renewal on payment of a surcharge of around 145 euros. The renewal fee is currently about 290 euros for the first class and 40 euros for each additional class, so a multi-class Lyon pharma mark should have its one-year window docketed early to renew before the surcharge applies.

Why do Lyon pharma brands need the French mark and the EUTM docketed separately?

Because they are two independent rights, due on different days and paid to different offices. The French national mark covers France and is renewed at the INPI; the EU trade mark covers all member states and is renewed at the EUIPO, each on its own ten-year clock from filing and each charging additional-class fees. A vaccine or diagnostic brand claimed across classes 1, 5 and 10 therefore pays per-class fees twice, once nationally and once at EU level, and the two deadlines rarely coincide. Renewing one does nothing for the other, so merging them into a single docket entry is how a right is lost.

Why do INPI opposition and revocation deadlines belong on a Lyon docket?

Since the loi PACTE, oppositions to French marks filed on or after 11 December 2019 run at the INPI, and from 1 April 2020 non-use revocation and many nullity actions are decided there too. An opposition must be filed within two months of publication with no extension, an opposed applicant has two months to file observations, and the INPI rules within three months of the adversarial phase closing. These reply windows are as fatal to miss as a renewal, so a sound Lyon docket diarises every contentious deadline alongside the renewal dates.

When is a Lyon trademark exposed to a non-use challenge?

A registered French mark that has not been put to genuine use for an uninterrupted period of five years can be revoked, and since 2020 that challenge can be filed at the INPI online by almost anyone for an official fee around 600 euros, with the proceeding capped at roughly nine months. The owner must prove genuine use, class by class, for the relevant period. Lyon pharma and biotech owners are especially exposed because defensive marks filed across many Nice classes often go unused in several of them, so the docket flags the five-year date and keeps dated proof of use current for every class.